VOM Hyaluronic Filler
High-viscosity biphasic dermal filler with 20mg/ml cross-linked HA + 0.3% lidocaine for deep tissue volumization
Multiphase Viscoelastic Technology
VOM utilizes patented STEEVâ„¢ technology (KR Patent 1020190034567) combining 20mg/ml of high-molecular-weight hyaluronic acid (1.2-2.4 million Da) with precision-engineered gel particles. The biphasic formulation demonstrates G’ modulus of 350-450 Pa at 2Hz frequency, ensuring optimal tissue integration and 12-18 month persistence. Manufactured under ISO 13485 certification with terminal sterilization (121°C/15psi for 20min), the product maintains <0.25% free HA content and 99.8% lidocaine stability.
Clinical Performance Data
Volume Restoration
94% maintenance of midface volume at 12 months (3D volumetric analysis, n=150)
Patient Satisfaction
98% reported ≥80% wrinkle improvement on FACE-Q scale at 6 months
Safety Profile
0.12% adverse event rate in 2,340 treatments (2023 post-market surveillance)
Pain Management
VAS score reduction of 82% compared to lidocaine-free formulations
Product Specifications
- Active Ingredients: Hyaluronic Acid 20mg/ml, Lidocaine HCl 3mg/ml
- Packaging: 2 pre-filled syringes × 1.0ml
- Needle Options: 25G 1/2″ (IM), 27G 1/2″ (SC)
- Viscosity: 350 Pa·s at 25°C
- Storage: 2-25°C protected from light
- Shelf Life: 24 months unopened
Injection Protocol
- Depth: Supraperiosteal/IM layer (4-6mm)
- Technique: Retrograde linear threading
- Max Volume/Site: 0.2ml per depot
- Needle Change: Every 2-3 entry points
- Post-care: Avoid pressure ×48hr
Clinical Applications
Deep Wrinkle Correction
For glabellar lines: 0.4-0.6ml total dose using 27G needle. Maintain 5mm safety margin from orbital rim. 92% improvement at 6 months.
Volumetric Restoration
Midface augmentation: 1.2-2.0ml per side via cannula. Layered supraperiosteal deposition shows 18-month persistence.
Contour Reshaping
Jawline definition: 0.8-1.2ml per side using 25G needle. Maintain 1cm anterior to mandibular angle.
Medical Practitioner Notice
Important: Clinical outcomes may vary depending on individual tissue characteristics and injection technique. Use only by certified dermatologists/plastic surgeons with advanced filler training. Strict contraindications include: active skin infections, hypersensitivity to lidocaine, and vascular compromise in treatment area.
This product is not FDA-approved. Always perform aspiration test before injection. Manufacturer (CG Bio Co., Ltd.) assumes no liability for off-label use or improper administration techniques. Results typically manifest over 2-4 weeks post-procedure.
Reviews
There are no reviews yet.